Tag: study

MN-166 COMBAT ALS trial down to single digit required enrollment while MN-001 hypertriglyceridemia trial in type 2 diabetes patients requires final two patients

Wuppertal, Germany, July 24, 2025 - Aicuris Anti-infective Cures AG today announced the completion of patient enrollment in its pivotal Phase 3 trial, PRIOH-1, evaluating pritelivir for the treatment of refractory and/or treatment resistant herpes simplex virus (HSV) infections in immunocompromised patients. The company’s lead candidate is a small molecule specifically inhibiting the viral helicase-primase complex, which represents a novel mechanism of action distinct from current HSV therapies.

SAN FRANCISCO, July 23, 2025 (GLOBE NEWSWIRE) -- When, on May 27, 2025, Rocket Pharmaceuticals (NASDAQ: RCKT) revealed that the FDA put a clinical hold on its Phase 2 pivotal trial for RP-A501, an experimental therapy intended to treat patients with a rare gene disorder called Danon disease, investors in the company’s shares saw their investment crash over 60% that day.

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Information Services Market size & share revenue was valued at approximately USD 168.37 Billion in 2024 and is expected to reach USD 179.73 Billion in 2025 and is expected to reach around USD 327.94 Billion by 2034, at a CAGR of 6.91% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Wolters Kluwer NV, United Press International Inc., Thomson Reuters Corp., The New York Times Co., S&P Global Inc., RELX Plc, Nexstar Media Group Inc., News Corp., Moody’s Corp., GISP Group, FUJIFILM Holdings Corp., Clarivate PLC, Bloomberg LP, Australian Associated Press Ltd., AGS Corp., Agence France Presse and others.